Sheryl McCoy
Sheryl McCoy publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes and Pancreatic and Hepatic Oncology Research.
- World rank
- #1,711,466 of 7,710,434 ranked researchers
- Rank in United States
- #528,847 of 1,627,098
- Works
- 16
- Citations
- 1.2k
- Citations per work
- 73.9
What does Sheryl McCoy research?
Sheryl McCoy's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (9%), Mathematics (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1166.6%
- Medicine1166.6%
- Everything else320.1%
- Life Sciences18.9%
- Physical Sciences14.4%
- Mathematics14.4%
- 1Oncology29% of their works
- 2Pulmonary and Respiratory Medicine22% of their works
- 3Surgery11% of their works
- 4Molecular Biology9% of their works
- 5Statistics and Probability4% of their works
- 6Gastroenterology4% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Treatments and Mutations
- Esophageal Cancer Research and Treatment
- Angiogenesis and VEGF in Cancer
- Gastrointestinal Tumor Research and Treatment
- Salivary Gland Disorders and Functions
Which keywords describe Sheryl McCoy's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Neoadjuvant Therapy, Cetuximab, Gastric Cancer, KRAS Mutations, Molecular Characterization and EGFR Mutations.
- VEGF
- Saliva
- Diagnostic Criteria
- Surgical Complications
- Pancreatic Cancer
- EGFR Mutations
- KRAS Mutations
- Cetuximab
- Endoscopic Resection
- Chemotherapy
- Neoadjuvant Therapy
- Gastric Cancer
- Molecular Characterization
- Esophageal Carcinoma
- Preoperative Chemoradiotherapy
- Targeted Therapy
- Imatinib Mesylate
- Sunitinib
- endothelial progenitor cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Chemotherapy133 topics
- Endoscopic Resection82 topics
- Neoadjuvant Therapy62 topics
- Cetuximab51 topic
- Gastric Cancer51 topic
- KRAS Mutations51 topic
- Molecular Characterization51 topic
- EGFR Mutations31 topic
- Esophageal Carcinoma31 topic
- Pancreatic Cancer31 topic
- Preoperative Chemoradiotherapy31 topic
- Surgical Complications31 topic
- Targeted Therapy31 topic
- Diagnostic Criteria21 topic
- Imatinib Mesylate21 topic
- Saliva21 topic
- Sunitinib21 topic
- VEGF21 topic
- endothelial progenitor cells21 topic
Where does Sheryl McCoy work?
Sheryl McCoy's main affiliation in the publication record is The University of Texas MD Anderson Cancer Center, United States.
How many publications and citations does Sheryl McCoy have?
OpenAlex counts 16 works and 1,183 citations for Sheryl McCoy, an h-index of 11, ranking #1,711,466 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sheryl McCoy. Posts are plain text and can be reported.